Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses

29 Nov 2002

Abstract excerpt

Flat urothelial hyperplasia, defined as markedly thickened urothelium without cytological atypia, is regarded in the new WHO classification as a urothelial lesion without malignant potential. Frequent deletions of chromosome 9 detected by fluorescence in situ hybridization (FISH) have been previously reported in flat urothelial hyperplasias found in patients with papillary bladder cancer. Using comparative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Genetic factors in colorectal cancer
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12474226
DOI: 10.1002/path.1259

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analysesPMID 12474226Read ↗

Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder.Semantic proximity Read ↗

Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancerSemantic proximity Read ↗

Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.Semantic proximity Read ↗

Analysis of genetic alterations in normal bladder urothelium.Semantic proximity Read ↗

Partial allelotype of carcinoma in situ of the human bladder.Semantic proximity Read ↗

Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytologySemantic proximity Read ↗

Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization.Semantic proximity Read ↗

Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization.Semantic proximity Read ↗

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.Semantic proximity Read ↗

Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder.Semantic proximity Read ↗

Genetic alterations in bladder cancer.Semantic proximity Read ↗

Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.